Healthy Skepticism Library item: 11364
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Leeman E.
The costs of compliance.
J Am Acad Psychoanal Dyn Psychiatry 2007 Sum; 35:(2):179-87
http://www.atypon-link.com/doi/abs/10.1521/jaap.2007.35.2.179
Abstract:
While the many costs of noncompliance have frequently been reviewed, this article addresses some of the costs of compliance, to the detriment of patients, doctors, and the doctor-patient relationship, and to the benefit of the pharmaceutical companies. Some psychiatric history is reviewed to analyze why psychiatric practice has become so focused on making specific diagnoses and treating those with specific medicines, even as fewer than 50% of patients follow medical advice. Some evidence for specific drug treatments is presented, and the powerful effects of nonspecific therapies, usually dismissed as confounders, are explored. Lastly, an argument for collaboration rather than compliance is made, imploring physicians to tailor individual treatment to each patient, and encouraging patients to be active in their own care.
Keywords:
Publication Types:
Historical Article
MeSH Terms:
Antidepressive Agents, Tricyclic/therapeutic use
Cooperative Behavior
Cost of Illness
Depressive Disorder/drug therapy
Drug Costs/statistics & numerical data
Drug Industry/methods
Drug and Narcotic Control/legislation & jurisprudence
History, 18th Century
History, 19th Century
History, 20th Century
History, Ancient
Humans
Legislation, Drug/standards
Marketing/methods
Mental Disorders/diagnosis
Mental Disorders/drug therapy*
Mental Disorders/therapy
Patient Compliance*/statistics & numerical data
Patient Participation
Physician's Practice Patterns
Physician-Patient Relations
Prescriptions, Drug/standards
Psychiatry/history
Psychiatry/methods
Psychotropic Drugs/therapeutic use*
United States
United States Food and Drug Administration/legislation & jurisprudence
Substances:
Antidepressive Agents, Tricyclic
Psychotropic Drugs
